Kwak Keum Yeon

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUNDS/AIMS It has been shown that adefovir dipivoxil is an effective antiviral agent in the treatment of chronic hepatitis B (CHB), not only in wild-type hepatitis B virus (HBV) infection, but also in lamivudine-resistant (LAMV-R) cases. However, little is known about the durability of the virologic response to adefovir in LAMV-R CHB patients. (More)
  • 1